COSMO PHARMACEUTICALS N.V.
26/05/2023 17:30
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
30/03/2023 07:00
Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
23/03/2023 07:00
Cosmo reports record 2022 financial results exceeding guidance, increased dividend by 10%, confirms 2023 guidance
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
22/03/2023 07:00
Cosmo Pharmaceuticals announces that Cosmo Intelligent Medical Devices – IMD Ltd, fully owned subsidiary of Cosmo Pharmaceuticals, and Medtronic to expand cooperation on GI Genius™
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
16/03/2023 07:00
Invitation to Cosmo’s full-year 2022 financial results and 2023 outlook webcast presentation on 23 March 2023
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
16/02/2023 07:00
Cosmo Pharmaceuticals reports record results for 2022, preliminary results exceeding guidance, increased dividend distribution and 2023 guidance
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
21/12/2022 07:00
Cosmo and Hyphens Announce Signing of License and Supply Agreements for Winlevi® in Southeast Asia
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
14/12/2022 07:00
Cosmo announces successful Phase III clinical trial of Lumeblue™ in China
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
20/10/2022 07:00
Cosmo announces FDA grants orphan-drug designation of rifamycin for treatment of pouchitis
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
COSMO PHARMACEUTICALS N.V.
12/10/2022 07:00
GI Genius™ named to FORTUNE 2022 “Change the World” list
Lire la news
Voir tous les communiqués de Cosmo Pharmaceuticals N.V.
1
2
3
4
5
6
7
8
9
10